0001333277-20-000005.txt : 20201014
0001333277-20-000005.hdr.sgml : 20201014
20201014132210
ACCESSION NUMBER: 0001333277-20-000005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201012
FILED AS OF DATE: 20201014
DATE AS OF CHANGE: 20201014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Quinlan Paul T
CENTRAL INDEX KEY: 0001333277
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 201238730
BUSINESS ADDRESS:
BUSINESS PHONE: 510-293-8123
MAIL ADDRESS:
STREET 1: C/O CYMABAY THERAPEUTICS, INC.
STREET 2: 7575 GATEWAY BLVD., SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7575 GATEWAY BOULEVARD
STREET 2: SUITE 110
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2020-10-12
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001333277
Quinlan Paul T
C/O CYMABAY THERAPEUTICS, INC.
7575 GATEWAY BOULEVARD, SUITE 110
NEWARK
CA
94560
0
1
0
0
General Counsel
Employee Stock Option (right to buy)
7.89
2020-10-12
4
A
0
275000
0
A
2030-10-11
Common Stock
275000
275000
D
The option vests as to 1/4 of the underlying shares on October 12, 2021, and vests as to 1/48 of the underlying shares monthly thereafter.
/s/ Paul Quinlan
2020-10-14